Literature DB >> 18680715

The hepcidin-binding site on ferroportin is evolutionarily conserved.

Ivana De Domenico1, Elizabeta Nemeth, Jenifer M Nelson, John D Phillips, Richard S Ajioka, Michael S Kay, James P Kushner, Tomas Ganz, Diane M Ward, Jerry Kaplan.   

Abstract

Mammalian iron homeostasis is regulated by the interaction of the liver-produced peptide hepcidin and its receptor, the iron transporter ferroportin. Hepcidin binds to ferroportin resulting in degradation of ferroportin and decreased cellular iron export. We identify the hepcidin-binding domain (HBD) on ferroportin and show that a synthetic 19 amino acid peptide corresponding to the HBD recapitulates the characteristics and specificity of hepcidin binding to cell-surface ferroportin. The binding of mammalian hepcidin to ferroportin or the HBD shows an unusual temperature dependency with an increased rate of dissociation at temperatures below 15 degrees C. The increased rate of dissociation is due to temperature- dependent changes in hepcidin structure. In contrast, hepcidin from poikilothermic vertebrates, such as fish or frogs, binds the HBD in a temperature-independent fashion. The affinity of hepcidin for the HBD permits a rapid, sensitive assay of hepcidin from all species and yields insights into the evolution of hepcidin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18680715      PMCID: PMC2660598          DOI: 10.1016/j.cmet.2008.07.002

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  35 in total

1.  Cytochrome b5 and cytochrome b5 reductase-phospholipid vesicles. Intervesicle protein transfer and oreintation factors in protein-protein interactions.

Authors:  H G Enoch; P J Fleming; P Strittmatter
Journal:  J Biol Chem       Date:  1977-08-25       Impact factor: 5.157

2.  Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features.

Authors:  Ronald L Sham; Pradyumna D Phatak; Carol West; Pauline Lee; Caroline Andrews; Ernest Beutler
Journal:  Blood Cells Mol Dis       Date:  2005 Mar-Apr       Impact factor: 3.039

3.  Serum ferritin and ageing.

Authors:  G Casale; C Bonora; A Migliavacca; I E Zurita; P de Nicola
Journal:  Age Ageing       Date:  1981-05       Impact factor: 10.668

4.  The C282Y mutation causing hereditary hemochromatosis does not produce a null allele.

Authors:  J E Levy; L K Montross; D E Cohen; M D Fleming; N C Andrews
Journal:  Blood       Date:  1999-07-01       Impact factor: 22.113

5.  The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation.

Authors:  Gaël Nicolas; Caroline Chauvet; Lydie Viatte; Jean Louis Danan; Xavier Bigard; Isabelle Devaux; Carole Beaumont; Axel Kahn; Sophie Vaulont
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

6.  Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.

Authors:  Elizabeta Nemeth; Marie S Tuttle; Julie Powelson; Michael B Vaughn; Adriana Donovan; Diane McVey Ward; Tomas Ganz; Jerry Kaplan
Journal:  Science       Date:  2004-10-28       Impact factor: 47.728

7.  Molecular analyses of patients with hyperferritinemia and normal serum iron values reveal both L ferritin IRE and 3 new ferroportin (slc11A3) mutations.

Authors:  Gilles Hetet; Isabelle Devaux; Nadem Soufir; Bernard Grandchamp; Carole Beaumont
Journal:  Blood       Date:  2003-05-01       Impact factor: 22.113

8.  Identification of a novel mutation (C321X) in HJV.

Authors:  Franklin W Huang; Isabel Rubio-Aliaga; James P Kushner; Nancy C Andrews; Mark D Fleming
Journal:  Blood       Date:  2004-05-11       Impact factor: 22.113

9.  Dominant hemochromatosis due to N144H mutation of SLC11A3: clinical and biological characteristics.

Authors:  Omer T Njajou; Gerard de Jong; Bianca Berghuis; Norbert Vaessen; Pieter J L M Snijders; Jan P Goossens; John H P Wilson; Martijn H Breuning; Ben A Oostra; Peter Heutink; Lodewijk A Sandkuijl; Cornelia M van Duijn
Journal:  Blood Cells Mol Dis       Date:  2002 Nov-Dec       Impact factor: 3.039

10.  Functional differences between hepcidin 1 and 2 in transgenic mice.

Authors:  Dan-Qing Lou; Gaël Nicolas; Jeanne-Claire Lesbordes; Lydie Viatte; Gisèle Grimber; Marie-France Szajnert; Axel Kahn; Sophie Vaulont
Journal:  Blood       Date:  2003-11-06       Impact factor: 22.113

View more
  56 in total

1.  Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice.

Authors:  Ivana De Domenico; Tian Y Zhang; Curry L Koening; Ryan W Branch; Nyall London; Eric Lo; Raymond A Daynes; James P Kushner; Dean Li; Diane M Ward; Jerry Kaplan
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

2.  Multiple regulatory mechanisms act in concert to control ferroportin expression and heme iron recycling by macrophages.

Authors:  Carole Beaumont
Journal:  Haematologica       Date:  2010-08       Impact factor: 9.941

Review 3.  Hepcidin and iron homeostasis.

Authors:  Tomas Ganz; Elizabeta Nemeth
Journal:  Biochim Biophys Acta       Date:  2012-01-26

4.  Hepatocyte-targeted HFE and TFR2 control hepcidin expression in mice.

Authors:  Junwei Gao; Juxing Chen; Ivana De Domenico; David M Koeller; Cary O Harding; Robert E Fleming; Dwight D Koeberl; Caroline A Enns
Journal:  Blood       Date:  2010-02-22       Impact factor: 22.113

5.  Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2.

Authors:  Ivana De Domenico; Eric Lo; Diane M Ward; Jerry Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-20       Impact factor: 11.205

Review 6.  Molecular mechanisms of normal iron homeostasis.

Authors:  An-Sheng Zhang; Caroline A Enns
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

7.  Time-of-flight mass spectrometry analysis of the ferroportin-hepcidin binding domain complex for accurate mass confirmation of bioactive hepcidin 25.

Authors:  David K Crockett; Mark M Kushnir; John D Phillips; Alan L Rockwood
Journal:  Clin Chim Acta       Date:  2009-12-03       Impact factor: 3.786

8.  Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS.

Authors:  Natascia Campostrini; Annalisa Castagna; Federica Zaninotto; Valeria Bedogna; Nicola Tessitore; Albino Poli; Nicola Martinelli; Antonio Lupo; Oliviero Olivieri; Domenico Girelli
Journal:  J Biomed Biotechnol       Date:  2010-04-15

9.  Hepcidin is elevated in mice injected with Mycoplasma arthritidis.

Authors:  Curry L Koening; Hong-Hua Mu; Adam Van Schelt; Eric Lo; Diane M Ward; Jerry Kaplan; Ivana De Domenico
Journal:  J Inflamm (Lond)       Date:  2009-11-24       Impact factor: 4.981

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.